Antiviral drug remdesivir may cut risk of death in adults with severe COVID and kidney or liver disease

Antiviral drug remdesivir may cut risk of death in adults with severe COVID and kidney or liver disease CIDRAP

This page contains an attributed headline and the preview text supplied through the publisher’s RSS feed. Copyright in the original reporting belongs to Google News — Technology.